Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy
Eye and Brain · 2016-05 · 81
DOI: 10.2147/eb.s94449 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Eye and Brain, 2016-05. Verfasst von Haibo Wang. Beteiligte Einrichtung: Department of Ophthalmology, John A Moran Eye Center, The University of Utah, Salt Lake City, UT, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, John A Moran Eye Center, The University of Utah, Salt Lake City, UT, USA.
Zitieren
APA
Wang, H. (2016). Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy. Eye and Brain, 81. https://doi.org/10.2147/eb.s94449
Vancouver
Wang H. Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy. Eye and Brain. 2016:81. doi:10.2147/eb.s94449
BibTeX
@article{Wang2016,
author = {Wang, Haibo},
title = {Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy},
journal = {Eye and Brain},
year = {2016},
pages = {81},
doi = {10.2147/eb.s94449}
}
EUVIMED